Total Joint Arthroplasty (TJA) Weight Loss Study
Osteoarthritis, Hip, Osteoarthritis, Knee, Obesity, Morbid
About this trial
This is an interventional treatment trial for Osteoarthritis, Hip focused on measuring Bariatric surgery, Medical weight loss, Total Hip Arthroplasty (THA), Total Knee Arthroplasty (TKA), Total Joint Arthroplasty (TJA), Body Mass Index >40 kg/m2, Prosthetic Joint Infection
Eligibility Criteria
Inclusion criteria:
- Patient must be 18 years or older who has met the clinical/standard care criteria for TJA (patient must have exhausted conservative measures to treat hip or knee joint arthritis (NSAIDS, physical therapy, corticosteroid injections)), except patient has a BMI > 40 kg/m2
- Patient must be interested in TJA as a treatment option
- Patient must be willing to be randomized to either a bariatric surgery study arm, a medical weight loss study arm, or a "usual standard of care" study arm
Exclusion Criteria:
- Patient has undergone prior laparoscopic sleeve gastrectomy or gastric bypass
- Patient has undergone prior hip or knee joint replacement for the affected joint
- Active substance use disorder
- Females with child-bearing potential
Sites / Locations
- Boston Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Other
Bariatric surgery group
Medical weight loss group
"Usual Standard of Care"
Participants randomized to the bariatric surgery arm will undergo either a laparoscopic sleeve gastrectomy or a laparoscopic gastric bypass to achieve a BMI ≤ 40 kg/m2.
Participants randomized to the medical weight loss study arm will attempt to lose weight through diet, exercise, and potentially pharmacotherapy an effort to lower their BMI to ≤ 40 kg/m2.
Patients randomized to the "usual standard of care" study arm will be counseled on the importance of losing weight to optimize their BMI and will be provided with referral information (name and clinic number) to either the bariatric surgery or medical weight loss clinics.